Advanced search
Publication Cover
Modern Rheumatology Volume 17, 2007 - Issue 1
Journal homepage
59
Views
44
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)

Hisashi YamanakaInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, JapanCorrespondence[email protected]
,
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan,Kitakyushu, Japan
,
Naoya SekiguchiDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University,Saitama, Japan
,
Eisuke InoueInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan,Kitakyushu, Japan
,
Hideto KamedaDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University,Saitama, Japan
,
Noriko IikuniInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
,
Masao NawataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan,Kitakyushu, Japan
,
Kouichi AmanoDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University,Saitama, Japan
,
Mikiko ShinozakiInstitute of Rheumatology, Tokyo Women's Medical University,10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan
&
Tsutomu TakeuchiDivision of Rheumatology and Clinical Immunology, Department of Internal Medicine, Saitama Medical Center, Saitama Medical University,Saitama, Japan
 show all
Pages 28-32 | Received 21 Aug 2006, Accepted 10 Oct 2006, Published online: 02 Jan 2014

References

  • Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356–61.
  • Kalden JR. Expanding role of biologic agents in rheumatoid ar-thritis. J Ftheumatol Suppl 2002;66:27–37.
  • Weaver AL. Efficacy and safety of the anti-TNF biologic agents. Modern Rheum 2004;14(4101–12.
  • Ostor AJ. Beyond methotrexate: biologic therapy in rheumatoid arthritis. Clin Med 2005;5(3):222–6.
  • Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumor necrosis factor a mono-clonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932–9.
  • Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594–602.
  • Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weis-man MH, et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among pa-tients with rheumatoid arthritis treated with infliximab and metho-trexate. Arthritis Rheum 2004;50:1051–65.
  • Miyasaka N, Takeuchi T, Eguchi K. Official Japanese Guidelines for the use of infliximab for rheumatoid arthritis. Modem Rheum 2005;15(1):4–8.
  • Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Com-parison of DA528-ESR and DA528-CRP on threshold values. Ann Rheum Dis 2006;in press [Epub ahead of print].
  • van Ftiel PL, van Gestel AM, van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br. J Ftheumatol 1996;35(Suppl 2):4–7.
  • Takeuchi T, Togo M, Etoh A, Suzuki T, Callegari PA, Gilmer KE. Safety of infliximab therapy in 4,475 Japanese patients with rheu-matoid arthritis: results from post marketing surveillance study (Abstract). Ann Rheum Dis 2006;65(Suppl II):503.
  • St Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432–43.
  • Klareskog L, van der Heijde D, de Jager JP, et al. TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators. Therapeutic effect of the com-bination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363(9410):675–81.
  • Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predict-ing response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43(422–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.